Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.

 
Web www.patentalert.com

< Glutaminyl based DPIV inhibitors

< Regulation of intracellular glucocorticoid concentrations

> Use of C2-substituted indan-1-one systems for preparing medicaments for the treatment of obesity

> Arylpiperazines having activity at the serotonin 1A receptor
~ 00208